Helsinn Healthcare S.A.: Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference

Helsinn to present data at upcoming AMMF's 2022 European Cholangiocarcinoma Conference Lugano, Switzerland, May 11, 2022 - Helsinn Group ("Helsinn"), a fully integrated, global biopharma company

Related Keywords

China ,Lugano ,Ticino ,Switzerland ,Ireland ,United Kingdom ,Essex ,Kostenloser Wertpapierhandel ,Paola Bonvicini ,Angela Lamarca ,Giorgio Calderari ,Gastroenterol Hepatol ,United Kingdom Cholangiocarcinoma Charity ,Linkedin ,European Network For The Study Of Cholangiocarcinoma ,Twitter ,Radisson Blu Hotel ,Helsinn Group ,Helsinn Birex Pharmaceuticals Ltd ,Group Head Of Communication ,Alan Morement Memorial Fund ,Co Glob Oncol ,Stansted Airport ,Kingdom Cholangiocarcinoma ,Fully Integrated Targeted Therapy ,Medical Oncologist ,Helsinn Birex Pharmaceuticals ,Genomic Analysis ,Cholangiocarcinoma Identifies Distinct ,Mutant Molecular ,Cell Rep ,Quan Lim ,Endemic Fluke Associated ,European Network ,Rev Gastroenterol Hepatol ,Media Contact ,Helsinn ,Healthcare ,Present ,Data ,Pcoming ,Wmmf ,022 ,European ,Cholangiocarcinoma ,Conference ,